Skip to content

Screening for Hypoglycemia in an Institutionalized Elderly Diabetic Population.

Screening for Hypoglycemia in an Institutionalized Elderly Diabetic Population.

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03656887
Acronym
HAGED
Enrollment
29
Registered
2018-09-04
Start date
2019-01-08
Completion date
2019-06-11
Last updated
2026-02-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Diabetes, Hypoglycemic Syndrome, Institutionalized in EHPAD (French Nursing Home), Old Age

Brief summary

Diabetes is a major public health problem that has been growing steadily in recent years. Its prevalence is very high in the elderly, in whom there is an increased risk of hypoglycemia. Hypoglycaemia in elderly diabetics has serious consequences: * increased mortality, * increased cardiovascular morbidity, * increased risk of falling, * impairment of quality of life. * Hypoglycaemia is also a risk factor for dementia in type 2 diabetes. The frequency of asymptomatic and atypical hypoglycemia has been shown to be greater in the elderly, but the exact prevalence of hypoglycemia in the elderly remains unknown. Elderly diabetic patients in institutions are particularly fragile and have more frequent cognitive problems than non-diabetic subjects. A study conducted in this population of patients showed that a third of them had HbA1C \<6.5%, which suggests a higher frequency of hypoglycemia though the figures were not available. We therefore decided to conduct a study to assess the frequency of hypoglycemia in order to better understand the contributing factors and to improve the management of this fragile population.

Interventions

DEVICEContinuous interstitial glucose sensor

Installing and removing the sensor

OTHERSensor Scan

Scan of the sensor, using the Freestyle Pro free version reader, at installation then before removal after 14 days.

Sponsors

Centre Hospitalier Universitaire Dijon
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
60 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* written consent * diabetic patient receiving treatment which could result in hypoglycemia: insulin and/or sulfonamide and/or glinides * institutionalized patient in an EHPAD * patient over 60 years of age

Exclusion criteria

\- person not affiliated to a national health insurance

Design outcomes

Primary

MeasureTime frame
Number of hypoglycemic events (<70 mg/dl) demonstrated by continuous interstitial glucose monitoring over the study period.Day 14
Number of hypoglycemic events (<70 mg/dl) detected by capillary blood glucose measurement or clinical signs suggestive of hypoglycemia.Day 14

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026